🤝 New partnership: AsedaSciences + Clyde Biosciences
We’re integrating CellOPTIQ® human-relevant cardiotoxicity data into the 3RnD® platform—enabling earlier, data-driven cardiac safety decisions within a modern NAM ecosystem.
Learn more: lnkd.in/eGJ9TRbd
@scicrunch.bsky.social #Cardiotoxicity
🤝 New partnership: AsedaSciences + Xenometrix
We’re integrating the Ames mutagenicity test into the 3RnD® platform—modernizing a regulatory-trusted assay to support earlier, NAM-based genotox decisions at scale.
Learn more: lnkd.in/e7DwHEBF
@scicrunch.bsky.social #Biotech #Genotoxicity #NAMs
🤝 New partnership: AsedaSciences® + GenEvolutioN®
We’re integrating best-in-class Micronucleus genotoxicity screening into the 3RnD® platform—enabling earlier, data-driven genotox assessment and broader adoption of NAMs.
Learn more: lnkd.in/e_8dxPcG
@scicrunch.bsky.social #Biotech #Genotoxicity
🤝 New Partnership: AsedaSciences + Redpine Technology AB
We’re integrating licensed scientific & clinical data into the 3RnD® platform—unlocking compliant, AI-ready insights to drive smarter decisions from discovery through development.
Learn more: lnkd.in/eRw4g8ki
@scicrunch.bsky.social #Biotech
🎉 Exciting news! AsedaSciences® is partnering with Hesperos!
Together, we’re connecting ML-guided toxicity insights with Human-on-a-Chip® systems to enable earlier, human-relevant decisions in R&D.
Learn more: www.asedasciences.com
@scicrunch.bsky.social #DrugDiscovery #Toxicology #Biotech
🥁 Big news! AsedaSciences® + AssayQuant are teaming up to integrate real-time Kinome Profiling into the 3RnD® platform—powering faster, smarter drug discovery with actionable kinase insights.
Learn more: lnkd.in/gAAKJe48
@scicrunch.bsky.social #DrugDiscovery #Kinome #AI #Biotech #LifeSciences
🧬 New collab: AsedaSciences® + Euretos!
Bridging disease biology, target selection & compound safety with AI + human-relevant toxicity data.
Smarter R&D starts here.
Learn more: lnkd.in/gUrDa6QT
@scicrunch.bsky.social #DrugDiscovery #AI #Biotech #Toxicology #TranslationalResearch
🔔 AsedaSciences® + Simplicis are teaming up! 3RnD® + Ledger platforms now offer a seamless workflow for compound screening & inventory management in small molecule R&D.
🔹 Real-time tracking
🔹 Automated screening
🔹 Full traceability
Learn more: lnkd.in/dFvxq2u7
@scicrunch.bsky.social #DrugDiscovery
🚀 AsedaSciences® is collaborating with Chemspace! Now you can access and order from 13B+ compounds via the 3RnD® platform.
🔍 Search, visualize, & explore with Compound Universe
⚗️ Streamline discovery in drug dev & beyond
Learn more: lnkd.in/giNSMYFm
@scicrunch.bsky.social #Chemspace #DrugDiscovery
🚀 Exciting news! AsedaSciences® and CellPort Software are partnering to enhance NAMs management, boosting data integrity, efficiency, and compliance in predictive toxicology.
Read more: lnkd.in/gme8g-PK
@scicrunch.bsky.social #NAMs #PredictiveToxicology #DrugDiscovery #AI #Biotech #LifeSciences
🚀 Exciting news! AsedaSciences® is attending #SOT! Visit us at Booth 604 to explore our latest innovations:
🔹 NAM Screening Services
🔹 3RnD Pilot Trials
🔹 Commercial Partnerships
Read more: lnkd.in/g3e53hrD
@scicrunch.bsky.social #DrugDiscovery #Pharma #PredictiveToxicology
🚀 More news from AsedaSciences®! Our BMC Screening Service with Dr. Klara Valko is here! 🔬⚡️
✅ Predict in vivo drug behavior early
✅ Fast, cost-effective compound screening
✅ Compare to 1,200+ drugs & 200+ agrochemicals in 3RnD®
Read more: lnkd.in/gqyZ3bzZ
@scicrunch.bsky.social #Biotech #Pharma
🚀 Exciting news from the Tanguay Lab & AsedaSciences®! ZBEScreen™ is here! 🐟⚡️
✅ Cost-effective zebrafish safety screening
✅ 70% genetic similarity to humans
✅ Compare results in 3RnD® with 800+ compounds
Read more: lnkd.in/gKqwhi5P
@scicrunch.bsky.social #LifeSciences #Biotech #Innovation
🚀 Exciting news! AsedaSciences® + Excelra are teaming up to boost small molecule research.
🎯 Integrating 3RnD® with GOSTAR® (10M+ structures) means faster insights, curated SAR data, & smarter decisions in drug discovery.
Read more: lnkd.in/gJaRY8TN
@scicrunch.bsky.social #DrugDiscovery